Medicare Enrolled
Dr. Mark Bergman, M.D.
Cardiovascular Disease · Huntington, NY
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bergman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bergman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bergman
Dr. Mark Bergman is a cardiovascular disease specialist in Huntington, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bergman performed 11,499 Medicare services across 7,161 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bergman received a total of $13,491 from 58 pharmaceutical and/or device companies across 693 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bergman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 2% volume in NY
$13,491 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,499
Medicare services
Top 2% in NY for cardiovascular disease
7,161
Unique beneficiaries
$143
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~605 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,904 | $76 | $164 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
1,970 | $42 | $103 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 982 | $313 | $400 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
586 | $13 | $89 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
530 | $70 | $148 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
500 | $65 | $380 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
491 | $1,227 | $3,800 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
475 | $22 | $248 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
474 | $48 | $298 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
474 | $209 | $548 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
473 | $178 | $497 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
337 | $7 | $44 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
245 | $180 | $640 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
243 | $7 | $30 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
200 | $117 | $263 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
111 | $36 | $40 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
109 | $72 | $75 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
86 | $149 | $350 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
58 | $12 | $35 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
58 | $1 | $25 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
33 | $256 | $350 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
22 | $807 | $1,500 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
22 | $175 | $250 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
21 | $23 | $200 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
20 | $94 | $200 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
20 | $34 | $35 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
16 | $16 | $20 |
| Strep A rapid test A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation. |
14 | $15 | $15 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
14 | $283 | $300 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
11 | $22 | $140 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.3% high complexity
41.3% medium
52.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,491
Total received (2018-2024)
Avg $1,927/year across 7 years
Top 17% in NY for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
693
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,491 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,855
2023
$1,888
2022
$2,345
2021
$2,345
2020
$1,276
2019
$2,086
2018
$1,695
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$194
Novartis Pharmaceuticals Corporation
$173
Amgen Inc.
$159
Merck Sharp & Dohme LLC
$141
Medtronic, Inc.
$127
Boehringer Ingelheim Pharmaceuticals, Inc.
$92
Impulse Dynamics (USA) Inc.
$91
Abbott Laboratories
$89
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$59
Azurity Pharmaceuticals, Inc.
$54
ABBVIE INC.
$49
Seqirus USA Inc
$49
Janssen Pharmaceuticals, Inc
$48
Lexicon Pharmaceuticals, Inc.
$46
PFIZER INC.
$44
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$41
Esperion Therapeutics, Inc.
$34
Exact Sciences Corporation
$34
GlaxoSmithKline, LLC.
$33
AstraZeneca Pharmaceuticals LP
$32
Corcept Therapeutics
$31
Regeneron Healthcare Solutions, Inc.
$30
E.R. Squibb & Sons, L.L.C.
$30
SANOFI PASTEUR INC.
$28
Sumitomo Pharma America, Inc.
$24
Kiniksa Pharmaceuticals International, plc
$23
Inspire Medical Systems, Inc.
$23
Daiichi Sankyo Inc.
$22
Lilly USA, LLC
$20
MEDICOMP INC
$20
Bayer Healthcare Pharmaceuticals Inc.
$16
Top 3 companies account for 28.4% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,229
Novartis Pharmaceuticals Corporation
$1,131
Novo Nordisk Inc
$884
Janssen Pharmaceuticals, Inc
$828
Boehringer Ingelheim Pharmaceuticals, Inc.
$791
Abbott Laboratories
$785
PFIZER INC.
$628
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$553
Amarin Pharma Inc.
$540
SANOFI-AVENTIS U.S. LLC
$409
Merck Sharp & Dohme LLC
$406
AstraZeneca Pharmaceuticals LP
$390
BOSTON SCIENTIFIC CORPORATION
$354
Astellas Pharma US Inc
$351
Esperion Therapeutics, Inc.
$346
Merck Sharp & Dohme Corporation
$301
Eisai Inc.
$231
E.R. Squibb & Sons, L.L.C.
$226
Kowa Pharmaceuticals America, Inc.
$225
Edwards Lifesciences Corporation
$182
Medtronic, Inc.
$175
Regeneron Healthcare Solutions, Inc.
$163
ARBOR PHARMACEUTICALS, INC.
$137
Penumbra, Inc.
$123
IDORSIA PHARMACEUTICALS US INC
$123
GlaxoSmithKline, LLC.
$114
Lundbeck LLC
$113
Bayer Healthcare Pharmaceuticals Inc.
$109
Arbor Pharmaceuticals, Inc.
$106
AtriCure, Inc.
$99
SANOFI PASTEUR INC.
$96
Lilly USA, LLC
$92
Impulse Dynamics (USA) Inc.
$91
AbbVie, Inc.
$89
Boston Scientific Corporation
$88
Azurity Pharmaceuticals, Inc.
$84
Gilead Sciences, Inc.
$75
ABBVIE INC.
$74
Allergan Inc.
$67
Lexicon Pharmaceuticals, Inc.
$66
MEDICOMP INC
$56
AbbVie Inc.
$49
Seqirus USA Inc
$49
Bayer HealthCare Pharmaceuticals Inc.
$47
Kiniksa Pharmaceuticals, Ltd.
$45
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$41
Shield Therapeutics Inc
$40
Bardy Diagnostics, Inc.
$36
Currax Pharmaceuticals LLC
$36
Exact Sciences Corporation
$34
Corcept Therapeutics
$31
Sumitomo Pharma America, Inc.
$24
Kiniksa Pharmaceuticals International, plc
$23
Inspire Medical Systems, Inc.
$23
Amryt Pharma Holdings Ltd
$23
HeartFlow, Inc.
$23
Daiichi Sankyo Inc.
$22
Althera Pharmaceuticals LLC
$17
Top 3 companies account for 24.0% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · ATRICURE SYNERGY ABLATION SYSTEM · Arcalyst · BASAGLAR · BELSOMRA · BRILINTA · BYSTOLIC · CAMZYOS · CARDIOMEMS · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · CYCLOSET · CardioMEMS HF System · Carnation Ambulatory Monitor · Cobalt · Cologuard Collection Kit · Corlanor · Dayvigo · EDARBI · ELIQUIS · ENTRESTO · EVKEEZA · Edarbi · Edarbyclor · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FFRct · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · Fluad · Flucelvax · GARDASIL · GARDASIL 9 · GEMTESA · HORIZANT · HeartMate 3 Left Ventricular Dev · Horizant · INJECTAFER · INSPIRE · Indigo System · Inpefa · JANUVIA · JARDIANCE · JUXTAPID · Kerendia · Korlym · LEQVIO · LEXISCAN · LINQ II · LYRICA · Lexiscan · LifeVest · Livalo · MITRACLIP · MOUNJARO · MULTAQ · Mitra Clip system · MitraClip System · NEXLETOL · NORTHERA · Optimizer · Ozempic · PNEUMOVAX 23 · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · QUVIVIQ · Ranexa · Repatha · Roszet · Rybelsus · SEGLENTIS · SYNTHROID · Saxenda · Synthroid · TELEPATCH CARDIAC MONITOR · TRELEGY ELLIPTA · TRULICITY · Tresiba · UBRELVY · VERQUVO · VESICARE · VYNDAQEL · Vascepa · Veozah · Victoza · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
807
Per 100K population
52.9
County median income
$128,329
Nearest hospital
NS/LIJ HS HUNTINGTON HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bergman is a cardiac imaging specialist, with above-average Medicare volume (top 2% in NY), with low-engagement industry engagement in the top 17% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bergman experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Bergman performed 2,904 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bergman receive payments from pharmaceutical companies?
Yes. Dr. Bergman received a total of $13,491 from 58 companies across 693 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bergman's costs compare to other cardiologists in Huntington?
Dr. Bergman's average Medicare payment per service is $143. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bergman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Huntington
Browse cardiologists in Huntington ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NY
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NY
Which NY cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology